DV
Dividend Vision

EMMA — Emmaus Life Sciences Inc

Emmaus Life Sciences Inc (EMMA)

Its deepest 1-year drawdown was 51.2%.

EMMA is an equity fund focused on a single stock—Emmaus Life Sciences Inc—established in 1996. The fund provides direct exposure to this biopharmaceutical company with no stated distribution frequency or yield profile. This structure appeals primarily to investors seeking concentrated exposure to Emmaus Life Sciences rather than those pursuing diversified dividend income.

EMMA key facts

Asset type
Stock
Asset class
Equity
Inception date
08/22/1996
Last close
$0.01
Market cap
$807,165
Average volume
120008.0
Payment date
07/18/2019
Beta
9.678
Payout ratio
0.0
Forward P/E
11.9048
EPS
$-0.13